处理高风险临床区域溶血血样:行动呼吁
该文由临床实验室、急诊科、成人及新生儿ICU的资深检验人员和医师共同撰写,总结体外溶血的医学重要性、体内溶血原因及美欧实验室溶血检测现状。体内溶血可由遗传异常、导致红细胞溶解的血红蛋白病及机械循环支持引起;体外溶血原因众多,急诊与ICU患者尤其易受血钾等错误实验室数据影响,治疗不当可致严重后果。认证机构虽有建议但非强制,溶血指数检测实施不普遍。作者据此提出教育预防、开展溶血检测、定义溶血报告水平、定期监测检测性能及规范高/正常血钾报告等建议。
要点
- 急诊与ICU患者因常用即时检测仪做全血电解质检测,尤其易受溶血导致的错误实验室数据(如血钾)影响,治疗不当可致严重后果。
- 体内溶血可由遗传异常、导致红细胞溶解的血红蛋白病及机械循环支持引起,常规实验室分析无法与体外溶血区分。
- 认证机构对溶血检测有建议但非强制,溶血指数检测的实施并不普遍。
- 作者建议开展预防教育、实施溶血检测、定义溶血报告水平、定期监测检测性能并规范高/正常血钾的实验室报告实践。
适用人群与场景
- 急诊科与重症监护室(含成人及新生儿ICU)采集的血标本,尤其是使用即时检测仪进行全血电解质检测的场景。
红旗征与不能漏的情况
- 急诊与ICU患者出现溶血标本时,血钾等电解质结果可能错误,依据错误数据治疗可导致严重后果。
研究设计与关键结果
- 该文为临床实验室、急诊科、成人及新生儿ICU的资深检验人员和医师共同撰写的总结,阐述体外溶血的医学重要性、体内溶血原因及美欧实验室溶血检测现状。
- 体内溶血可由遗传异常、导致红细胞溶解的血红蛋白病及机械循环支持引起;体外溶血原因众多,常规实验室分析无法区分体内与体外溶血。
- 认证机构对溶血检测有建议但非强制,溶血指数检测的实施不普遍。
- 作者就预防教育、开展溶血检测、定义溶血报告水平、定期监测检测性能及高/正常血钾报告实践提出建议。
证据类型、等级与局限
- 证据类型:专家综述与行动呼吁(来自临床实验室、急诊科、成人及新生儿ICU的资深检验人员和医师)。
- 局限:原文未报告局限性
对床旁实践的改变
- 作者建议对急诊与ICU标本开展溶血检测,定义溶血报告水平,定期监测溶血检测性能,并规范高与正常血钾的实验室报告实践。
- 作者建议开展教育以预防溶血,因为认证机构的相关建议并非强制且溶血指数检测实施不普遍。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Spectrophotometric testing to detect sample hemolysis is available from central laboratory chemistry analyzers. While the cause and preventative measures are known, hemolysis continues to be a common preanalytical error, especially for specimens collected from the emergency department (ED) and intensive care units (ICUs) where point-of-care analyzers are commonly used for whole blood electrolyte testing. Recently, these analyzers have employed technology to detect hemolysis directly on whole blood samples.
METHODS: Experienced laboratorians and physicians from the clinical laboratory, ED, adult and neonatal ICUs provide a summary of the medical importance of in vitro hemolysis. Causes for in vivo hemolysis are summarized as it is indistinguishable from in vitro hemolysis from routine laboratory analysis. The detection of hemolysis by clinical laboratories is discussed from the American and European perspectives.
RESULTS: In vivo hemolysis can occur due to genetic abnormalities, hemoglobinopathies that cause red cell lysis, and mechanical circulatory support. There are many causes of in vitro hemolysis. Patients in the ED and ICU are particularly vulnerable to erroneous laboratory data such as potassium. Incorrectly treated patients can lead to significant medical consequences. Within the clinical laboratory, there are recommendations made by accrediting bodies, but none are mandatory, and the implementation of the hemolysis index testing is not universal.
CONCLUSIONS: Recommendations have been authored regarding the need for education for prevention, performance of hemolysis detection testing, defining levels of hemolysis reporting, periodic monitoring of hemolysis detection performance, and laboratory reporting practices for high and normal potassium test results.
参考来源
- Wu AHB, Levy JH, Peacock WF, et al. Handling Hemolytic Blood Samples from High-Risk Clinical Areas: A Call to Action. J Appl Lab Med. 2025. PMID: 40709795. doi:10.1093/jalm/jfaf082
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。